A meta-analytic approach to estimating nocebo effects in neuropathic pain trials

Journal of Neurology

Volumn 259, Issue 3, 2012, Pages 436-447

  Papadopoulos, Dimitrios ^a,b   Mitsikostas, Dimos Dimitrios ^a  

^a ATHENS NAVAL HOSPITAL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Meta analysis; Meta regression; Neuralgia; Neuropathic pain; Nocebo

Indexed keywords

PLACEBO;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDLINE; MENTAL DISEASE; NEUROPATHIC PAIN; NOCEBO EFFECT; PATIENT COMPLIANCE; PLACEBO EFFECT; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGED; AGED, 80 AND OVER; ANALGESICS; FEMALE; HUMANS; MALE; MEDLINE; MIDDLE AGED; NEURALGIA; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS;

EID: 84862533769     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6197-4     Document Type: Article

References (50)

1. Amanzio M, Corazzini LL, Vase L, Benedetti F (2009) A systematic review of adverse events in placebo groups of antimigraine clinical trials. Pain 146:261-269
2. Balant LP, Balant-Gorgia EA (2000) Cultural differences: implications on drug therapy and global drug development. Int J Clin Pharmacol Ther 38:47-52 (Pubitemid 30077978)
3. Barsky AJ, Saintfort R, Rogers MP, Borus JF (2002) Nonspecific medication side effects and the nocebo phenomenon. JAMA 287:622-662
4. Berman S, Munakata J, Naliboff BD, Chang L, Mandelkem M, Silverman D, Kovalik E, Mayer EA (2000) Gender differences in regional brain response to visceral pressure in IBS patients. Eur J Pain 4:157-172 (Pubitemid 30470027)
5. Berger A, Dukes EM, Oster G (2004) Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 5:143-149 (Pubitemid 38879392)
6. Bouhassira D, Lantiri-Minet M, Attal N, Laurent B, Touboul C (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380-387 (Pubitemid 351680253)
7. Cairns DM, Adkins RH, Scott MD (1996) Pain and depression in acute traumatic spinal cord injury: origins of chronic problematic pain. Arch Phys Med Rehabil 77:329-335 (Pubitemid 26111746)
8. Davis C, Ralevski E, Kennedy SH, Neitzert C (1995) The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers. J Clin Psychopharmacol 15:347-352
9. de la Cruz M, Hui D, Parsons HA, Bruera E (2010) Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer 116:766-774
10. Deeks JJ (2001) Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 323:157-162 (Pubitemid 32678396)
11. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
12. Dworkin RH, Corbin AE, Young JP Jr., Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM (2003) Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60:1274-1283 (Pubitemid 36460982)
13. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132:237-251 (Pubitemid 350051570)
14. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634 (Pubitemid 27387172)
15. Enck P, Benedetti F, Schedlowski M (2008) New insights into the placebo and nocebo responses. Neuron 59:195-206 (Pubitemid 352033692)
16. Flaten MA, Simonsen T, Olsen H (1999) Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosom Med 61:250-255 (Pubitemid 29168656)
17. Gimbel JS, Richards P, Portenoy RK (2003) Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 60:927-934 (Pubitemid 36348923)
18. Hall GC, Carroll D, Parry D, McQuay HJ (2006) Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 122:156-162
19. Jensen MP, Romano JM, Turner JA, Good AB, Wald LH (1999) Patient beliefs predict patients functioning; further support for a cognitive-behavioural model of chronic pain. Pain 81:95-104 (Pubitemid 29199905)
20. Jensen MP, Chodroff MJ, Dworkin RH (2007) The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 68:1178-1182 (Pubitemid 46608464)
21. Kennedy WP (1961) The nocebo reaction. Med Exp Int J Exp Med 95:203-205
22. Klosterhalfen S, Kellermann S, Braun S, Kowalski A, Schrauth M, Zipfel S, Enck P (2009) Gender and the nocebo response following conditioning and expectancy. J Psychosom Res 66:323-328
23. Lesser H, Sharma U, LaMoreaux L, Poole RM (2004) Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 63:2104-2110 (Pubitemid 39636259)
24. Liccardi G, Senna G, Russo M, Bonadonna P, Crivellaro M, Dama A, D'Amato M, D'Amato G, Canonica GW, Passalacqua G (2004) Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions. J Invest Allergol Clin Immunol 14:104-107 (Pubitemid 38987680)
25. Loder E, Goldstein R, Biondi D (2005) Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls. Cephalalgia 25:124-131 (Pubitemid 40193955)
26. Macedo A, Baños JE, Farré M (2008) Placebo response in the prophylaxis of migraine: a meta-analysis. Eur J Pain 12:68-75 (Pubitemid 350046365)
27. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
28. Mitsikostas DD, Mantonakis LI, Chalarakis NG (2011) Nocebo is the enemy, not placebo: a meta-analysis of reported side effects after placebo treatment in headaches. Cephalalgia 31:550-561
29. Mitsikostas DD, Thomas AM (1999) Comorbidity of headache and depressive disorders. Cephalalgia 19:211-217 (Pubitemid 29268493)
30. Moher D, Liberati A, Tetzlaff J, Altmann DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:332-336
31. Connor AB O (2009) Neuropathic pain. Quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics 27:95-112
32. Otto M, Bach FW, Jensen TS, Sindrup SH (2004) Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial. Neurology 62:285-288 (Pubitemid 38167141)
33. Papadopoulos D, Mitsikostas DD (2010) Nocebo effects in multiple sclerosis trials: a meta-analysis. Mult Scler 16:816-828
34. Paulson PE, Minoshima S, Morrow TJ, Casey KL (1998) Gender differences in pain perception and patterns of cerebral activation during noxious heat stimulation in humans. Pain 76:223-229 (Pubitemid 28304960)
35. Ploghaus A, Narain C, Beckmann CF, Clare S, Bantick S, Wise R, Matthews PM, Rawlins JN, Tracey I (2001) Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci 21:9896-9903 (Pubitemid 34184074)
36. Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, Royall RM, Max MB (2002) Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebocontrolled trial. Neurology 59:1015-1021
37. Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, Gross HM, Renno SI, Nashawaty M, Loprinzi CL (2008) Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 112:2802-2808 (Pubitemid 351969227)
38. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI, CAPSS-141 Study Group (2004) Topiramate vs. placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 63:865-873 (Pubitemid 39297649)
39. Rintala DH, Loubser PG, Castro J, Hart KA, Fuhrer MJ (1998) Chronic pain in a community-based sample of men with spinal cord injury: prevalence, severity, and relationship with impairment, disability, handicap, and subjective well-being. Arch Phys Med Rehabil 79:604-614 (Pubitemid 28265709)
40. Rosenzweig P, Brohier S, Zipfel A (1993) The placebo effect in healthy volunteers: influence of experimental conditions on the adverse events profile during phase I studies. Clin Pharmacol Ther 54:579-583
41. Sawamoto N, Honda M, Okada T, Hanakawa T, Kanda M, Fukuyama H, Konishi J, Shibasaki H (2000) Expectation of pain enhances responses to nonpainful somatosensory stimulation in the anterior cingulate cortex and parietal operculum/posterior insula: an event-related functional magnetic resonance imaging study. J Neurosci 20:7438-7445
42. Semenchuk MR, Sherman S, Davis B (2001) Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology 57:1583-1588 (Pubitemid 33055474)
43. Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy TK (2006) Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 67:1792-1800 (Pubitemid 44900755)
44. Simpson DM, Schifitto G, Murphy TK, Durso-De Cruz E, Glue P, Whalen E, Emir B, Scott GN, Freeman R, HIV Neuropathy Study Group (2010) Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology 74:413-420
45. Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS (2003) Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 60:1284-1289 (Pubitemid 36460983)
46. Sindrup SH, Jensen TS (1999) Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83:389-400
47. Torrance N, Smith BH, Bennett MI, Lee AJ (2006) The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7:281-289
48. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70:1630-1635 (Pubitemid 351620320)
49. Uhlenhuth EH, Alexander PE, Dempsey GM, Jones W, Coleman BS, Swiontek AM (1998) Medication side effects in anxious patients: negative placebo responses. J Affect Dis 47:183-190 (Pubitemid 28066774)
50. Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, Raskin J (2006) A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 67:1411-1420 (Pubitemid 44632065)